Page 1

CO RE

2018

ANNUAL REPORT


CONTENTS CONTENTS

2018 ANNUAL 2018REPORT ANNUAL REPORT

EST. 2000EST. 2000

05 05 11 Funding

Funding

Annual Retreat

2018 ANNUAL REPORT 2018 ANNUAL REPORT

01 01

CORE at aatGlance CORE a Glance Year Highlights Year Highlights

06 06 Publications

Publications


02 02

03 03

OurOur Research Areas Research Areas

Graduate andand Post Graduate Post Graduate Trainees Graduate Trainees

Recognitions andand Recognitions Highlights Highlights

Faculty Faculty

Clinical Trainees & & Clinical Trainees Undergraduate Students Undergraduate Students

09 09 Collaborations

Collaborations

10 10 Teaching

Teaching

2018 ANNUAL REPORT 2018 ANNUAL REPORT


CORE at a Glance Whoat Are We? CORE a Glance Housed The University of British Columbia’s Faculty of Pharmaceutical Sciences, the Collaboration Housed withinwithin The University of British Columbia’s Faculty of Pharmaceutical Sciences, the Collaboration for Outcomes Research and Evaluation (CORE) is an academic research established in 2000. Led by for Outcomes Research and Evaluation (CORE) is an academic research groupgroup established in 2000. Led by Director, Dr. Larry CORE’s is toevidence-based lead evidence-based evaluations to improve health-related Director, Dr. Larry Lynd,Lynd, CORE’s visionvision is to lead evaluations to improve health-related outcomes locally, nationally, and internationally. outcomes locally, nationally, and internationally. The overarching goal our research is to improve health-related outcomes through the application The overarching goal of ourofresearch is to improve health-related outcomes through the application of of thein best in research, education, and practice enhancement strategies. to provide the best the best research, education, and practice enhancement strategies. CORECORE strivesstrives to provide the best evidence to inform practice, and future research at improving clinical outcomes, quality evidence to inform practice, policy,policy, and future research aimedaimed at improving clinical outcomes, quality of of life,economic and economic benefits of health interventions. is achieved through a combination of indepenlife, and benefits of health interventions. This isThis achieved through a combination of independentcollaborative and collaborative multidisciplinary research programs including engagement with patients, dent and multidisciplinary research programs including engagement with patients, clini- cliniresearchers, makers, and both and private stakeholders. cians,cians, otherother researchers, policypolicy makers, and both publicpublic and private sectorsector stakeholders.

Year Highlights Year Highlights JOURNALS JOURNALS

50 50

REVIEWED PEERPEER REVIEWED JOURNAL ARTICLES JOURNAL ARTICLES

COMPLETEDACTIVE ACTIVE COMPLETED

6 6 1515

TRAINEES TRAINEES and Postdoctoral Fellows supervised CORE Faculty) (Masters,(Masters, PhD, andPhD, Postdoctoral Fellows supervised by COREby Faculty)

16 16 COURSES COURSES TAUGHT TAUGHT

1

2018 ANNUAL REPORT REPORT 12018 ANNUAL

AWARDED AWARDED

3.4 3.4

M M

FUNDING FUNDING

(Newand grants and contracts COREas Faculty as Principal Investigator/Applicant) (New grants contracts awardedawarded to CORE to Faculty Principal Investigator/Applicant)


Recognitions and Highlights Recognitions and Highlights Congratulations Dr. Larry Lynd for being inducted as a Fellow Congratulations to Dr.to Larry Lynd for being inducted as a Fellow of theof the Canadian Academy of Health Sciences (CAHS), considered Canadian Academy of Health Sciences (CAHS), considered one ofone theof the highest honours Canada’s academic community. Fellows highest honours withinwithin Canada’s academic community. CAHSCAHS Fellows are nominated byinstitutions their institutions and peers and selected in a competare nominated by their and peers and selected in a competitive process oninternationally their internationally recognized leadership, itive process basedbased on their recognized leadership, academic performance, scientific creativity and willingness to serve. academic performance, scientific creativity and willingness to serve. pledges to serve Canadians by volunteering theand time and CAHSCAHS pledges to serve Canadians by volunteering the time expertise our Fellows expertise of ourofFellows in in Canadian Canadian conducting independent, conducting independent, Academy of Academy of unbiased, assessments unbiased, expertexpert assessments on on HealthHealth health-related of major health-related topicstopics of major Sciences Sciences Fellow Fellow importance to Canada. importance to Canada.

New New Investigator Investigator Research Research AwardAward

Congratulations Dr. Mohsen Sadatsafavi Congratulations to Dr.to Mohsen Sadatsafavi for for receiving the Association of Faculties of Pharreceiving the Association of Faculties of Pharof Canada 2018Investigator New Investigator macymacy of Canada 2018 New Research that recognizes outstanding Research AwardAward that recognizes outstanding research achievements and contributions research achievements and contributions of theof the members the academic staff of juniorjunior members of theof academic staff of Faculties, Colleges or Schools of Pharmacy Faculties, Colleges or Schools of Pharmacy in in Canada. Canada.

Our Research Areas Our Research Areas

DISEASE MODELING DISEASE MODELING

PHARMACY PRACTICE PHARMACY RESEARCH PRACTICE GLOBAL RESEARCH HEALTH

HEALTH SERVICES RESEARCH HEALTH SERVICES RESEARCH GLOBAL HEALTH

HEALTH ECONOMICS HEALTH ECONOMICS EPIDEMIOLOGY/ EPIDEMIOLOGY/ CLINICAL EVALUATION CLINICAL EVALUATION

PHARMACOEPIDEMIOLOGY PHARMACOEPIDEMIOLOGY 2018 ANNUAL REPORT2 2018 ANNUAL REPORT

2


Faculty Faculty PETER LARRY PETER LARRY ZED ZED LYNDLYND PhD, BSP PhD, BSP PharmDPharmD

Professor & Professor & Professor & Professor & Director, Associate Director, CORE CORE Associate Dean, Dean, Practice Innovation Practice Innovation e. larry.lynd@ubc.ca e. peter.zed@ubc.ca e. larry.lynd@ubc.ca e. peter.zed@ubc.ca p. 604 827 3397 p. 604 827 0178 p. 604 827 3397 p. 604 827 0178

PETER FAWZIAH PETER FAWZIAH LOEWEN (MARRA) LOEWEN LALJILALJI (MARRA) PharmDPharmD PharmDPharmD

Professor Associate Professor Professor Associate Professor

e. fawziah.lalji@ubc.ca e. peter.loewen@ubc.ca e. fawziah.lalji@ubc.ca e. peter.loewen@ubc.ca p. 604 822 7898 p. 604 827 1814 p. 604 822 7898 p. 604 827 1814

MARY MARK MARY MARK DE VERA HARRISON DE VERA HARRISON PhD

PhD PhD

PhD

Assistant Professor Assistant Professor Assistant Professor Assistant Professor

e. mary.devera@ubc.ca e. mark.harrison@ubc.ca e. mary.devera@ubc.ca e. mark.harrison@ubc.ca p. 604 827 2138 p. 604 827 0687 p. 604 827 2138 p. 604 827 0687

ANNALIJN MOHSEN ANNALIJN MOHSEN CONKLIN SADATSAFAVI CONKLIN SADATSAFAVI PhD (CANTAB), PhD (CANTAB), MPH MPH MD, PhDMD, PhD

Assistant Professor Assistant Professor Assistant Professor Assistant Professor

e. annalijn.conklin@ubc.ca e. mohsen.sadatsafavi@ubc.ca e. annalijn.conklin@ubc.ca e. mohsen.sadatsafavi@ubc.ca p. 604 827 4258 p. 604 827 3020 p. 604 827 4258 p. 604 827 3020

3

32018 ANNUAL 2018 ANNUAL REPORT REPORT


Graduate and Post Graduate Trainees Graduate and Post Graduate Trainees COMPLETED COMPLETED

ACTIVE ACTIVE

Alison Pearce Alison Pearce Solmaz Ehteshami Solmaz Ehteshami Afshar Afshar

Magda Aguiar Magda Aguiar Mohsen Mohsen YaghoubiYaghoubi

Alyssa Howren Alyssa Howren Ariana Saatchi Ariana Saatchi Celestin Celestin HategekaHategeka Kate Johnson Kate Johnson Mohammed Atiquzzaman Mohammed Atiquzzaman Nelson Gorrin Nelson Gorrin Nirma Vadlamudi Nirma Vadlamudi Norma Biln Norma Biln RebeccaRebecca MetcalfeMetcalfe ShahrzadShahrzad Salmasi Salmasi

Campbell JonathonJonathon Campbell Natalie McCormick Natalie McCormick Nicole Tsao Nicole Tsao

not available not available

James Hicklin James Hicklin

Khalid Saad El Din Khalid Saad El Din Nevena Rebic Nevena Rebic Ross Duncan Ross Duncan

Postdoctoral Postdoctoral FellowsFellows

PhD PhD Students Students

MastersMasters Students Students

Clinical Trainees & Undergraduate Students Clinical Trainees & Undergraduate Students Adam Mah Adam Mah Renee Dagenais Renee Dagenais

Abdo Sourya Abdo Sourya Hill AinsleighAinsleigh Hill Brian NgBrian Ng Caitlin Chew Caitlin Chew ChristineChristine Lukac Lukac Enavzipora Enavzipora Zusman Zusman Jamie Park Jamie Park Jenny GuJenny Gu

Joy Que Joy Que Lau KathleenKathleen Lau Kane Larson Kane Larson Lester LinLester Lin Lilly Lin Lilly Lin Rachel Tandun Rachel Tandun RebeccaRebecca Wang Wang Tara Luk Tara Luk

PharmD PharmD Students/ Students/ Residents Residents

* *

Undergraduate Undergraduate Students Students

*Undergraduate students, , and undergraduate academic assistants supervised. *Undergraduate studentsstudents include:include: SummerSummer students, directeddirected studies ,studies and undergraduate academic assistants supervised.

2018 ANNUAL REPORT4 2018 ANNUAL REPORT

4


Funding Funding

(Newand grants and contracts awarded CORE Faculty as Principal Investigator/Applicant) (New grants contracts awarded to COREtoFaculty as Principal Investigator/Applicant)

Source Source

Project Project TitleTitle

Total Total Amount to CORE Amount to CORE

BC Support BC Support Unit Unit

Economic Methods to Design Using Using HealthHealth Economic Methods to Design Patient-Oriented Clinical Studies Patient-Oriented Clinical Studies

$57,550 $57,550

Canadian for Applied Canadian CentreCentre for Applied Research in Cancer Research in Cancer ControlControl Seed Seed Grant Grant

Connected to address the informaConnected healthhealth to address the information and support needs of patients tion and support needs of patients and and survivors of young-onset colorectal survivors of young-onset colorectal cancercancer

$29,945 $29,945

Canadian Institutes of Health Canadian Institutes of Health Research Research ProjectProject Grant Grant

Examining epidemiology, treatment, Examining epidemiology, treatment, and and outcomes in young-onset colorectal outcomes in young-onset colorectal cancercancer (EXPLAIN-yCRC) (EXPLAIN-yCRC)

$459,000 $459,000

MethaPharm, Inc.company) (U.S. company) MethaPharm, Inc. (U.S.

Technology Assessment of systematic HealthHealth Technology Assessment of systematic implementation of objective diagnostic implementation of objective diagnostic testingtesting for asthma for asthma in the in U.Sthe U.S

$116,737 $116,737

Michael Foundation Michael Smith Smith Foundation for for Research Convening & HealthHealth Research Convening & Collaborating Collaborating grant grant

Building new partnership between the FNHA Building a new apartnership between the FNHA andfor UBC for community-based research to and UBC community-based research to improve Indigenous women’s heart health improve Indigenous women’s heart health

$14,980 $14,980

Pfizer Canada Pfizer Canada

Perspectives on multidisciplinary care for Perspectives on multidisciplinary care for patients with rheumatic disease patients with rheumatic disease in BC in BC

$50,000 $50,000

UBC Collaborative Research UBC Collaborative Research Mobility Awards (VP Research & Mobility Awards (VP Research & Innovation) Innovation)

Building new UBC-UW collaboration Building a new aUBC-UW collaboration for a for a research cluster on the social determinants of research cluster on the social determinants of nutrition-related outcomes nutrition-related outcomes

$14,390 $14,390

Vancouver Research Vancouver CoastalCoastal HealthHealth Research Institute Institute

Economic Methods to Design Using Using HealthHealth Economic Methods to Design Patient-Oriented Clinical Studies Patient-Oriented Clinical Studies

$153,020 $153,020

Vancouver Research Vancouver CoastalCoastal HealthHealth Research Institute Institute

The burden of comorbidity in patients with Economic burden of pediatric asthma severe asthma

$148,132 $148,132

(Teaminvolving grants involving CORE Faculty) (Team grants CORE Faculty)

Source Source

Project Project TitleTitle

Total Total Amount to CORE Amount to CORE (Total amount awarded ) (Total amount awarded )

Genome Columbia (adminis- GenCOUNSEL: GenCOUNSEL: Optimization of Genetic $935,954 Optimization of Genetic Coun-Coun- $935,954 Genome BritishBritish Columbia (adminis($4,200,000) ($4,200,000) lead), Génome Québec for Clinical Implementation of trativetrative lead), Génome Québec seling seling for Clinical Implementation of Genome-Wide Sequencing Genome-Wide Sequencing

5

MS Society of Canada, MS Society of Canada, Brain Brain Canada, BioGen, and Roche Canada, BioGen, and Roche

The Canadian Proactive The Canadian Proactive CohortCohort Study Study for for with Multiple Sclerosis PeoplePeople LivingLiving with Multiple Sclerosis (CanProCo) (CanProCo)

$938,000 $938,000 ($8,715,000) ($8,715,000)

Genome Canada Genome Canada

Childhood Asthma and the Microbiome Childhood Asthma and the Microbiome Precision HealthHealth for Lifefor Life Precision

$436,290 $436,290 ($9,142,486) ($9,142,486)

REPORT 2018 ANNUAL REPORT 52018 ANNUAL


Publications Publications A

Chen W, Sin DD, FitzGerald JM, Conklin AI, Yao C, Richardson CG. Dragojlovic N, Kim E, Elliott A, Friedman Chen W, Sin DD, FitzGerald JM, Conklin AI, Yao C, Richardson CG. Chronic Dragojlovic N, Kim E, Elliott A, Friedman Sadatsafavi M. The Impact of Care Chronic sleep deprivation and risk of J, Lynd LD. Evaluating the use of parental Sadatsafavi M. The Impact of Care sleep deprivation and risk of depression J, Lynd LD. Evaluating the use of parental Al Efraij K, Johnson KM, Wiebe D, Specialty on Survival-Adjusted Medical depression in adolescents: a prospective reports to estimate healthcare resource Al Efraij K, Johnson KM, Wiebe D, Specialty on Survival-Adjusted Medical in adolescents: a prospective population reports to estimate healthcare resource Sadatsafavi M, FitzGerald JM. A Costs of COPD Patients After a population based study from a gender utilization in children with suspected Sadatsafavi M, FitzGerald JM. A Costs of COPD Patients After a based study from a gender perspective. utilization in children with suspected systematic review of the adverse events Hospitalization: a longitudinal analysis. J perspective. BMC Public Health, 2018 genetic disorders. J Eval Clin Pract. 2018 systematic review of the adverse events Hospitalization: a longitudinal analysis. J BMC Public Health, 2018 Jun 18:724 genetic disorders. J Eval Clin Pract. 2018 and economic impact associated with Gen Intern Med. 2018 Apr 2. doi: Jun 18:724 Apr;24(2):416-422. doi: 10.1111/and economic impact associated with Gen Intern Med. 2018 Apr 2. doi: Apr;24(2):416-422. doi: 10.1111/oral corticosteroids in asthma. J Asthma. 10.1007/s11606-018-4406-x. PMID: jep.12876. PMID: 29603523 oral corticosteroids in asthma. J Asthma. D 10.1007/s11606-018-4406-x. PMID: jep.12876. PMID: 29603523 2018 Dec 4:1-13 D 29611088 2018 Dec 4:1-13 29611088 E Dagenais R, Zed PJ. Intranasal lidocaine E C Dagenais R, Zed PJ. Intranasal lidocaine Conklin AI, Daoud A, Shimkhada R., C for management of primary headache: a Conklin AI, Daoud A, Shimkhada R., for management of primary headache: aElliott AM, Elliott du C, Souich N. The of impact of soaring du AM, Souich AdamC,S,Adam S, Ponce N.Ponce The impact soaring food food systematic review. Pharmacotherapy Campbell JR, Johnston JC, LA, Ronald LA, systematicfirst review. Pharmacotherapy Dragojlovic N, van Karnebeek C, Nelson prices on obesity in women: A Campbell JR, Johnston JC, Ronald 2018;38:1038-50, published on-line Dragojlovic N, van Karnebeek C, Nelson prices on obesity in women: A Sadatsafavi M, Balshaw published on-line TN, Lehman TN, Lehman Lynd LD, Friedman JM. longitudinal in 31 Sadatsafavi M, Balshaw RF, CookRF, VJ,Cook LevinVJ, Levin ahead of2018;38:1038-50, print August 11,first 2018 A, LyndA, LD, Friedman JM. longitudinal analysisanalysis in 31 lowandlow- and F. Screening for Latent ahead of print August 11, 2018 The Genomic Consultation A middle-income countries. International https://doi.org/10.1002/phar.2169 A, MarraA, F. Marra Screening for Latent The Genomic Consultation Service:Service: A middle-income countries. International Tuberculosis in Migrants https://doi.org/10.1002/phar.2169 designed to improve of Obesity, 2018 Aug. [Epub Tuberculosis InfectionInfection in Migrants With With Journal Journal clinical clinical service service designed to improve of Obesity, 2018 Aug. [Epub CKD: A Cost-effectiveness selection for genome‐wide print] doi: CKD: A Cost-effectiveness Analysis.Analysis. Am J Am Jahead ofahead Dalen D, Fry A, Campbell SG, Eppler J, patient patient selection for genome‐wide print]of doi: Kidney Sep 28. pii: Dalen D, Fry cefazolin A, Campbell Eppler J, sequencing inColumbia. British Columbia. 10.1038/s41366-018-0178-y Kidney Dis. 2018Dis. Sep2018 28. pii: Zed PJ. Intravenous plusSG, oral sequencing in British Mol Mol 10.1038/s41366-018-0178-y S0272-6386(18)30878-3. PMID: 30269868 Zed PJ. cefazolin Genet Genomic Med. 2018 S0272-6386(18)30878-3. PMID: 30269868 probenecid vs. Intravenous oral cephalexin for theplus oral Genet Genomic Med. 2018 May 30.May doi:30. doi: probenecid vs.soft oraltissue cephalexin for the 10.1002/mgg3.410. AI, Guo Tam ACT, 10.1002/mgg3.410. treatment of skin and Conklin Conklin AI, Guo SXR, TamSXR, ACT, W, FitzGerald LD, Sin DD, treatment of skin and soft tissue Richardson CG. Gender, life Chen W,Chen FitzGerald JM, LyndJM, LD,Lynd Sin DD, infections: a prospective, non-inferiority, Richardson CG. Gender, stressfulstressful life Sadatsafavi M. Long-term trajectories of infections: a prospective, non-inferiority, F events, and interactions witha sleep: a randomized Sadatsafavi M. Long-term trajectories of controlled trial. Emerg Med F events, and interactions with sleep: mild in asthma in adulthood randomized Emerg Med systematic review of determinants of J 2018;35:492-8, mild asthma adulthood and risk and risk firstcontrolled published trial. on-line systematic review of determinants of factors of progression. Int J Clin Allergy Clin Flanagan PS, Briseño-Garzón A, Zed PJ, first published adiposity young people. BMJ Open, ahead ofJ 2018;35:492-8, factors of progression. Int J Allergy PS, Briseño-Garzón A, Zed PJ, print June 18, 2018 http://dx.-on-line Flanagan adiposity in younginpeople. BMJ Open, Immunol: In Practice. 2018 Nov-Dec:6(6): Strain RM.Outcomes Safety Outcomes With Home ahead of print June 18, 2018 http://dx.- Strain RM. 2018;8:e019982. doi: 10.1136/bmjop- doi.org/10.1136/emermed-2017-207420 Immunol: In Practice. 2018 Nov-Dec:6(6): Safety With Home 2018;8:e019982. doi: 10.1136/bmjop2024-2032.e5. doi: 10.1016/j.Assessment (SO WHAT): a doi.org/10.1136/emermed-2017-207420Assessment en-2017-019982 2024-2032.e5. doi: 10.1016/j.Trial (SOTrial WHAT): a * en-2017-019982 jaip.2018.04.027 mixed-methods evaluation of jaip.2018.04.027 mixed-methods evaluation of Dragojlovic Elliott AM,S,Adam medication in thecare home care AI, Tam ACT, Guo SXR, Dragojlovic N, ElliottN,AM, Adam Van S, Van medication safety insafety the home Conklin Conklin AI, Tam ACT, Guo SXR, W, Johnson KM, FitzGerald JM, Richardson Karnebeek C, Lehman A, Mwenifumbo setting.setting. Home Care Health Care Management Richardson Doesidentificaethnic identifica- Karnebeek Chen W,Chen Johnson KM, FitzGerald JM, C, Lehman A, Mwenifumbo Home Health Management CG. DoesCG. ethnic Sadatsafavi Leslie WD. Long-term tion moderate JC, TN, Nelson TN, Du C, Souich C, Friedman JM, & Practice 2018;30:76-82, first published tion moderate the of impact of depressionJC, Nelson Sadatsafavi M, LeslieM, WD. Long-term Du Souich Friedman JM, & Practice 2018;30:76-82, first published the impact depression of corticosteroids inhaled corticosteroids on on obesity LD. Estimating ahead print January on obesity young people?: results of aLynd LD.Lynd effects ofeffects inhaled on Estimating the costthe andcost and on-line on-line ahead of printof January 27, 201827, 2018 in younginpeople?: results of a bone mineral density older women systematic cost-effectiveness of diagnostic systematic review. Adolescent cost-effectiveness bone mineral density in older in women of diagnostic exome exome https://-https://scopingscoping review. Adolescent with or asthma a registry-based ResearchResearch sequencing for children doi.org/10.1177/1084822318754844 2018 April: 1-14 [epubsequencing with asthma COPD:oraCOPD: registry-based servicesservices for children with with doi.org/10.1177/1084822318754844 Review, Review, 2018 April: 1-14 [epub cohortArch study. Arch Osteoporos. suspected disorders. Genet Med. print] https://cohort study. Osteoporos. 2018 Oct2018 Octahead ofahead suspected geneticgenetic disorders. Genet Med. print]of https://29;13(1):116 2018:1013 20(9): 1013 – 1021. doi.org/10.1007/s40894-018-0085-4 2018: 20(9): 29;13(1):116 – 1021. doi.org/10.1007/s40894-018-0085-4 A

We found strong link found aa strong link ““We between food price inflation between food price inflation

and obesity adult womeninin and obesity inin adult women developing countries whichis is developing countries which clearly modified individuals' clearly modified byby individuals' SES SES

””

AI, A, Daoud A, Shimkhada R.,N. Ponce N. The impact ConklinConklin AI, Daoud Shimkhada R., Ponce The impact of soaring foodon prices on obesity in women: A of soaring food prices obesity in women: A longitudinal in 31 lowand middle-income longitudinal analysisanalysis in 31 lowand middle-income countries. International JournalJournal of Obesity, 2018 Aug. countries. International of Obesity, 2018 Aug. [Epub ahead print]ofdoi: 10.1038/s41366-018-0178-y [Epubof ahead print] doi: 10.1038/s41366-018-0178-y

5.159 5.159 IMPACT IMPACT FACTOR FACTOR

2018 2018 ANNUAL REPORT ANNUAL REPORT

6

6


H

JohnsonJohnson KM, Tan WC, Bourbeau J, Sin J, Sin population-based study. Lupus. Singhal MarraS,F, Marra F, KM, Tan WC, Bourbeau population-based study.2018 Lupus. 2018 Stein K, Farmer Stein K,J,Farmer J, S, Singhal DD, Sadatsafavi M. The diagnostic Jul;27(8):1247-1258. doi: Sutherland S, Quiñonez C. The use and use and DD, Sadatsafavi M. The diagnostic Jul;27(8):1247-1258. doi: Sutherland S, Quiñonez C. The Haag H, Liang JA, De JA, De performance of patient in PMID: PMID: misuse of antibiotics in dentistry: A Haag T, H,Avina-Zubieta Liang T, Avina-Zubieta performance ofsymptoms patient symptoms in 10.1177/0961203318768882. 10.1177/0961203318768882. misuse of antibiotics in dentistry: A Vera MA.Vera HowMA. do Patients Systemic screening for COPD.forRespir 2018Res. 2018 29665755 scoping scoping review. Jreview. Am Dent Assoc. How do with Patients with Systemic screening COPD.Res. Respir 29665755 J Am Dent2018 Assoc. 2018 Autoimmune Rheumatic Disease Disease Aug 3;19(1):147. PMID:30075717 Oct;149(10):869-884. Autoimmune Rheumatic Aug 3;19(1):147. PMID:30075717 Oct;149(10):869-884. Perceive Perceive the Use of their A MouminMoumin NA, HouNA, K, Michaux KD, the UseMedications: of their Medications: A Hou K, Michaux KD, Systematic Review and Thematic Kaal KJ, Harrison M, Whitehust DGT, A, Mundy PorterG,K,Porter Li H, Lynd T Systematic Review and Thematic Kaal KJ, Harrison M, Whitehust DGT, Stormer Stormer A,G, Mundy K, Li H, Lynd T SynthesisSynthesis of Qualitative Research.Research. BMC A, DanceA,D,Dance StoesslD,AJ, Illes J.AJ, Illes J.LD, Talukder Z, GreenZ, T. Green ImpactT.of of Qualitative BMCTownsonTownson Stoessl LD, Talukder Impact of H, FitzGerald JM, LyndJM, LD,Lynd LD, Rheumatology.2018 Dec 1;2:9Dec doi:1;2:9 doi: Commentary: Operationalizing enhanced homestead food production H, FitzGerald Rheumatology.2018 Commentary: Operationalizing enhanced homestead food productionTavakoliTavakoli Sadatsafavi M. Predictors of inappropri10.1186/s41927-018-0017-8 neuroimaging for disorders of programprogram on household food production Sadatsafavi M. Predictors of inappropri10.1186/s41927-018-0017-8 neuroimaging for disorders of on household food ate and excessive use of reliever consciousness. CanadianCanadian Journal of intake ofand women aged ate and excessive use of reliever consciousness. Journal of and dietary production dietary intake of Hall J, Kaal KJ,J,Lee Duncan Tsao N,R, Tsao N,Neurological in asthma: a 16 yeara 16 year Sciences.Sciences. AcceptedAccepted 16th and children agedyear 6-59 Hall KaalJ,KJ, Lee J, R, Duncan medications in asthma: Neurological 16th 15-49 year women aged 15-49 and children medications Harrison Harrison M. Patient and population based- study. Pulm (In2018. Press,(In Commentary) months:aged a pragmatic, delayed cluster M.satisfaction Patient satisfaction and June 2018. population based-BMC study. BMC Pulm June Press, Commentary) 6-59 months: a pragmatic, costs of multidisciplinary models of care of care Med. 2018 Feb2018 12;18(1):33. doi: randomized controlled protocol.controlled Int costs of multidisciplinary models Med. Feb 12;18(1):33. doi: delayed clustertrial randomized in rheumatology: A reviewAofreview the recent K 10.1186/s12890-018-0598-4. PMID: PMID: J Clin Trials. Nov;4(4):157-165. doi: in rheumatology: of the recent K 10.1186/s12890-018-0598-4. trial2017 protocol. Int J Clin Trials. 2017 literature.literature. Current Rheumatology 29433489 http://dx.Current Rheumatology 29433489 Nov;4(4):157-165. doi: http://dx.Kelly A, Tong MarchK,L,March Craig L, Craig Reports 2018. 20 2018. (4):1920 (4):19 KellyA, A,Tymms Tong A,K,Tymms doi.org/10.18203/2349-3259.ijct201748 Reports doi.org/10.18203/2349-3259.ijct201748 JC, De Vera Evans V, Evans Hassett Tsao NW,Tsao Lynd LD,Lynd Sadatsafavi M, JC, MA, De Vera MA, V, G, Hassett G, NW, LD, Sadatsafavi M, 63 63 Harrison Harrison M, Han PKJ, Rabin B, Rabin Bell M,B, Bell M, Toupin-April K, vanden B, Bemt B, Hanley G, De Vera MA.Vera Patterns of M, Han PKJ, Toupin-April K, Bemt vanden Hanley G, De MA. Patterns of Kay H, Spooner L, Peacock S, Bansback A, Alten R, utilization and discontinuaSpooner L, Milbers Hudson Kay H, Spooner L, Peacock S, BansbackTeixeira-Pinto Teixeira-Pinto A, Bartless Alten R, SJ, Bartless SJ, Munro S,Munro utilization and discontinuaS, Spooner L, K, Milbers K, Hudsonbiologicsbiologics N. Communicating uncertainty in CampbellCampbell W, Dawson T, Gill M, T,Hebing tion before during in Harrison M. Perspectives of N. Communicating uncertainty in W, Dawson Gill M, R, Hebing M, R, KoehnM,C,Koehn tionand before andpregnancy during pregnancy in C, Harrison M. Perspectives of cancer prognosis: A reviewAofreview of Meara A,Meara Nieuwlaat R, Shaw Y, JA,Singh JA, women women with autoimmune diseases:diseases: A patients,patients, first-degree relativesrelatives and cancer prognosis: A, Nieuwlaat R,Singh Shaw Y, with autoimmune A first-degree and web-based prognostic tools. Patient M, Simpton D, WongD, P, Wong P,rheumatologists population-based cohort study. on preventive web-based prognostic tools. Patient Suarez-Almazor Suarez-Almazor M, Simpton population-based cohort study. rheumatologists on preventive Education and Counseling 2018. 2018. Christensen R, BeatonR,D, de WitD,M,de Wit M, Care ResCare (Hoboken). 2018 Jun; treatments for rheumatoid arthritis:arthritis: A Education and Counseling Christensen Beaton Res (Hoboken). 2018 Jun; treatments for rheumatoid A ArthritisArthritis Published Online 12Online Dec 2018. pii:2018. pii: Tugwell P. Outcome MeasuresMeasures in doi: 10.1002/acr.23434. Qualitative Analysis.Analysis. BMC RheumatoloPublished 12 Dec Tugwell P. Outcome in 70(7): 979-986. doi: 10.1002/acr.23434. Qualitative BMC Rheumatolo-70(7): 979-986. S0738-3991(18)31017-6 Rheumatology – Interventions for PMID: 28973840 gy. 2018gy. 2:18 S0738-3991(18)31017-6 Rheumatology – Interventions for PMID: 28973840 2018 2:18 Medication Adherence (OMERACT-AdMedication Adherence (OMERACT-AdHarrison Harrison M, Quisias Frew E,J,Albon S. Albon S. herence)herence) Tsao NW,Tsao Sayre EC,Sayre Hanley Core Domain Set for Trials of Trials of N M,J,Quisias Frew E, NW, EC,G, Hanley G, Core Domain Set for N AssessingAssessing the valuethe of investment in Sadatsafavi M, Lynd M, LD,Lynd Marra De CA, De for Medication Adherence value of investment in Interventions Sadatsafavi LD,CA, Marra Interventions for Medication Adherence teachingteaching and learning technology by a Najafzadeh, M, UngarM,WJ, HadioonsaRiskMA. of preterm deliverydelivery and 5 Phase Study and learning technology by ain Rheumatology: Najafzadeh, Ungar WJ, Hadioonsa- Vera MA.Vera Risk of preterm and in Rheumatology: 5 Phase Study Faculty ofFaculty Pharmaceutical Sciences:Sciences: a Comparing births inbirths in Trials. 2018 Mar2018 27;19(1):204 of Pharmaceutical a Protocol.Protocol. dehN, A,Lynd Tsao LD. N, Lynd LD. Comparing small-for-gestational-age small-for-gestational-age Trials. Mar 27;19(1):204 deh A, Tsao cost-benefit analysis. analysis. AmericanAmerican Journal Journal differentdifferent experimental designs designs for women women with autoimmune disease using cost-benefit experimental for with autoimmune disease of Pharmaceutical Education 2018. 2018. Kuenzig Kuenzig ME, Sadatsafavi M, Aviña-Zubibest-worst scaling choice before or during pregnancy: a of Pharmaceutical Education ME, Sadatsafavi M, Aviña-Zubibest-worst scalingexperiments: choice experiments:biologicsusing biologics before or during (Epub ahead ofahead print) of print) eta JA, Burne RM, Abrahamowicz M, of asthma J Health study. Ann (Epub eta JA, Burne RM, Abrahamowicz M, the casethe case of control. asthma Int control. Int J Healthpopulation-based pregnancy:cohort a population-based cohort Beauchamp ME, Kaplan Benchimol 2018Res May:1:3-16 doi: Rheum Dis. 2018; 869-74. . doi: 77(6): Beauchamp ME,GG, Kaplan GG, BenchimolPref Res Pref 2018 May:1:3-16 doi: study. Ann77(6): Rheum Dis. 2018; HategekaHategeka C, Taboulsee T, McMullen K, not associated with thewith the 10.21965/IJHPR.2018.001. 10.1136/annrheumdis-2018-213023. C, Taboulsee T, McMullen K, EI. Asthma EI. is Asthma is not associated 10.21965/IJHPR.2018.001. 869-74. . doi: 10.1136/annrheumLynd LD.Lynd Unemployment and informal surgery Crohn's LD. Unemployment and informalneed forneed for in surgery in disease Crohn's disease dis-2018-213023. care are associated with stigma V when controlling for smoking status: a status: aR care are associated withinstigma in R when controlling for smoking multiple multiple sclerosis.sclerosis. Int J MS Care. 2018. cohort study. Clin Int J MS Care. 2018. population-based V population-based cohort study. Clin A, WilcoxA,ES, Townsend ePub ahead ofahead print: http://ijmsc.org/Rai SK, Howren Wilcox ES, TownsendVadlamudi N, Chen A, Marra F. Impact of 2018 Jul 2018 12;10:831-840. ePub of print: http://ijmsc.org/-Epidemiol. Epidemiol. Jul 12;10:831-840. Rai SK, Howren AF, MarraAF, CA, Avina-Zubieta JA, De Vera pneumococcal conjugate doi/pdf/10.7224/1537-2073.2017-108 Marra CA, Avina-Zubieta JA, De Vera13-valent Vadlamudi N, Chen A, Marra F. Impact of doi/pdf/10.7224/1537-2073.2017-108 PMID: 30038523 PMID: 30038523 MA. Exploring strategies to support adults: a systematic MA. Exploring strategies to support vaccine among 13-valent pneumococcal conjugate Hiligsmann M, Rademacher S, Kaal KJ,S, Kaal KJ,L medication adherence in patients with meta-analysis. Clin Infect Dis Hiligsmann M, Rademacher medication adherence in patients withreview and vaccine among adults: a systematic L BansbackBansback N, Harrison M. The use inflammatory arthritis:arthritis: A patient-orient2018 (in review press) and meta-analysis. Clin Infect Dis N, Harrison M. of The use of inflammatory A patient-orientroutinelyroutinely collectedcollected patient-reported M, ed qualitative study using anusing interactive patient-reported Ling D, Anis LingA,D,Lynd AnisL,A,Harrison Lynd L, Harrison M, ed qualitative study an interactive 2018 (in press) outcomeoutcome measuresmeasures in rheumatoid BansbackBansback N. Early economic evaluations focus group in rheumatoid N. Early economic evaluations focusactivity. group Patient activity.Preference Patient PreferenceVadlamudi NK, Marra F. Influenza among arthritis. arthritis. SeminarsSeminars in Arthritis and for making decisions to investto ininvest inand Adherence. 2018 Oct2018 5;2018(12); Vadlamudi NK, adults Marra F.living Influenza in Arthritis and for better making better decisions and Adherence. Oct 5;2018(12); vaccine uptake children. Journal of adults living Rheumatism. 2018 (Epub ahead ofahead of personalized medicinemedicine technologies. doi: 10.2147/PPA.S174672. vaccine uptake among Rheumatism. 2018 (Epub personalized technologies. 2015-25.2015-25. doi: 10.2147/PPA.S174672. with young Epidemiological Research print) print) Journal of Comparative Effectiveness with young children. Journal of Journal of Comparative Effectiveness Ronald LA, Campbell JR, Balshaw RF, ResearchResearch 2018; 8(1). Published Ronald LA, Campbell JR, Balshaw RF, 2018;4(1):41-48 Epidemiological Research 2018; 8(1). Published Howren A, Cox SM, K, Rai SK,K, Rai SK, Online:10Online:10 Romanowski K, Roth DZ, Marra F, Marra Cook F, Cook Dec 2018Dec 2018 Howren A, Shojania Cox SM, Shojania Romanowski K, Roth DZ, 2018;4(1):41-48 van Boven JFM, van de Hei SJ, Choi HK, Choi De Vera HowMA. patients with VJ, Johnston JC. Demographic HK, MA. De Vera How patients with VJ, Johnston JC. Demographic Sadatsafavi Making of Hei SJ, gout become engagedengaged in disease Lynd LD,Lynd Henrich Hategeka C, Marra C, Marra predictors of activeof tuberculosis in van M. Boven JFM,sense van de gout become in disease LD, NJ, Henrich NJ, Hategeka predictors active tuberculosis in cost-effectiveness in sense of management: A constructivist CA, Mittmann N, EvansN, C, Evans Traboulsee T. to BritishtoColumbia, Canada: Canada: a Sadatsafavianalyses M. Making management: A constructivist CA, Mittmann C, Traboulsee T.migrantsmigrants British Columbia, a respiratory medicine: a practical guide grounded theory study. Arthritis Perspectives of patients with multiple cohort study. CMAJ cost-effectiveness analyses in grounded theory study. Arthritis Perspectives of patients with multiple retrospective retrospective cohort study. CMAJ for non-health economists. Eura Respir J. guide ResearchResearch and Therapy. 2018 Jun2018 Jun sclerosis sclerosis on drug on treatment: a 2018;Feb2018;Feb 26:190:E209-E216 respiratory medicine: practical and Therapy. drug treatment: a 26:190:E209-E216 2018 Dec 1;20(1):110. doi: qualitative study. Intstudy. J MS Care. 2018; 202018; 20 for21non-health economists. Eur Respir J. 1;20(1):110. doi: qualitative Int J MS Care. S 10.1186/s13075-018-1608-x. PMID: PMID: (6): 269-77doi: S 2018 Dec 21 10.1186/s13075-018-1608-x. (6): 269-77doi: Verbowski V, Talukder Z, Hou K, Sok 29859127. 10.7224/1537-2073.2017-109 29859127. 10.7224/1537-2073.2017-109 Sadatsafavi M, Gustafson P, Zafari Z, Sin Z, SinHoing, L,Verbowski Michaux K, Sadatsafavi M, Gustafson P, Zafari V, Anderson Talukder Z,V,Hou K, Sok DD. Relative impact characteristic curve: curve: Gibson R, Li K, Lynd LD, McLean J, Humphrey N, Hennesey A, Lendrum A, DD. Relative impact characteristic Hoing, L, Michaux K, Anderson V, Humphrey N, Hennesey A, Lendrum A,M M a graphical tool to visualize and Green, TJ, Barr S.R,Effect of enhanced Wigelsworth M, TurnerM,A,Turner Panayiotou M, a graphical tool to visualize and Gibson Li K, Lynd LD, McLean J, Wigelsworth A, Panayiotou M, Mamun A, Zhao B, M, Dreher quantifyquantify the clinical and homestead food and Joyce C, Pert E, Wo L, E, Wo L, Mamun A,McCabe Zhao B, McCabe M,K,Dreher K, theutility clinical utility and Green, TJ,production Barr S. Effect of enhanced JoyceK,C,Stephens Pert K, Stephens E, Marra E, F, Patrick CostDM. Costpopulation-level consequences of aquaculture on dietary intakes of Squires G, WoodsG,K,Woods Harrison M, CalamM, CalamBlondel-Hill Blondel-Hill Marra F,DM. Patrick population-level consequences of homestead food production and Squires K, Harrison a population-based markers.markers. Ann Epidemiol. and childrenon in rural Cambodia: R. The PATHS curriculum for promoting benefit of analysis of a population-basedimplementing implementing Ann Epidemiol.women aquaculture dietary intakes of R. The PATHS curriculum for promotingbenefit analysis education programprogram on the wise usewise of use of2018 Jul2018 30. pii: a clusterwomen randomized controlled trial. Cambodia: social and emotional well-being among among education on the Jul 30. pii: and children in rural social and emotional well-being Pharmacoeconomics S1047-2797(18)30005-X. PMID: PMID: Matern Child Nutr. 2018 Jun; controlled trial. children children aged 7 9aged years:7a9cluster antibiotics. Pharmacoeconomics S1047-2797(18)30005-X. a cluster randomized years: aRCT. cluster RCT. antibiotics. (in-press). 30107972 14(3):e12581. doi: 10.1111/mcn.12581. Public Health 2018 6(10) 2018;3:119 (in-press). 30107972 Matern Child Nutr. 2018 Jun; PublicResearch. Health Research. 2018 6(10) 2018;3:119 PMID: 29314705 14(3):e12581. doi: 10.1111/mcn.12581. Marra F, McCabe M, Patrick A Salmasi S, Kwan L, J, J Marra F, McCabe M,D.Patrick D. A Salmasi S, MacGillivray Kwan L, MacGillivray J, J PMID: 29314705 decreasedecrease in antibiotic utilization for N, De Vera Barry AR,Barry AR, Z in antibiotic utilization for Bansback Bansback N, MA, De Vera MA, Johnson Johnson KM, Safari A, Tan WC, urinary tract infections in women MJ, Andrade J, Lynd LD, KM, Safari A, Bourbeau Tan WC, Bourbeau urinary tract infections in in women in HarrisonHarrison MJ, Andrade J, Lynd LD, Z Zafari Z, Sadatsafavi M, Chen W, J, FitzGerald JM, Sadatsafavi M. long term careterm facilities. CanadianCanadian Loewen Loewen P. Assessment of atrial of atrial J, FitzGerald JM, Sadatsafavi M. long care facilities. P. Assessment JM. Z, The projected M, economic Heterogeneity in the respiratory GeriatricsGeriatrics Journal 2018;21(3):262-263 patients’patients’ education needs needs FitzGerald Zafari Sadatsafavi Chen W, Heterogeneity in the respiratory Journal 2018;21(3):262-263 fibrillation fibrillation education burden JM. of sub-optimal symptoms of patients with from patient clinician perspectives: FitzGerald The projected economic symptoms of patients with fromand patient and clinician perspectives:and health N, MarraN, CA, Sadatsafavi M, in Canada. Med. mild-to-moderate COPD. IntCOPD. J Chron study. Throm 2018; In 2018; Inasthma control McCormick Marra CA, Sadatsafavi M,a qualitative and health burdenRespir of sub-optimal mild-to-moderate Int J Chron McCormick a qualitative study.Res Throm Res Aviña-Zubieta JA. Incremental direct direct Press. doi: 2018 May;138:7-12. doi:in Canada. Respir Med. ObstructObstruct Pulmon Dis. 2018Dis. Dec2018 Dec 10.1016/j.thromAviña-Zubieta JA. Incremental asthma control Pulmon Press. doi: 10.1016/j.thrommedical costs of systemic lupus lupus 10.1016/j.rmed.2018.03.018. PMID: 13;13:3983-3995 res.2018.11.015 medical costs of systemic 2018 May;138:7-12. doi: 13;13:3983-3995 res.2018.11.015 erythematosus patients patients in the years 29724396 erythematosus in the years 10.1016/j.rmed.2018.03.018. PMID: preceding diagnosis: A general preceding diagnosis: A general 29724396

7

H

REPORT 2018 ANNUAL REPORT 7 2018 ANNUAL


““

We found a asubstantial We found substantial reduction ofofinvasive reduction invasive pneumococcal pneumococcaldisease disease (IPD) from vaccine (IPD) from vaccine serotypes ininadults serotypes adultsafter after introduction introductionofofthe the 13-valent pneumococ13-valent pneumococcal conjugate cal conjugatechildhood childhood immunization immunizationprogram, program, but also aa modest but also modest increase ininnon-vaccine increase non-vaccine serotype-related serotype-related IPD. IPD. TOPOP

T N N I I 0% 101%

d d ade loc-ade o l n wnnfe al w o oI c st d loinsticdal Cselisni eases Mo M a m C Dis froise m fro ous D ctnioaluss nals ti Inofeur our J J

9.117 9.117

””

Vadlamudi NK, Chen Marra Impact of 13-pneumococcal conjugate vaccinevaccine Vadlamudi NK,A,Chen A,F.Marra F. Impact of 13-pneumococcal conjugate amongamong adults: adults: a systematic review review and meta-analysis. Clin Infect 2018; a systematic and meta-analysis. ClinDis Infect Disdoi: 2018; doi: 10.1093/cid/ciy872. [Epub ahead of print] 10.1093/cid/ciy872. [Epub ahead of print]

IMPACT IMPACT FACTOR FACTOR

2018 2018 ANNUAL REPORT ANNUAL REPORT

8

8


Collaborations Collaborations Annalijn ConklinConklin Annalijn

Larry Lynd Larry Lynd

Peter Zed Peter Zed

Fawziah Lalji Lalji Fawziah

Mark Harrison Mark Harrison

Peter Loewen Peter Loewen

of Health BC Health Vice-Chair, BC Ministry BC Ministry of Health BC Technology Health Technology Vice-Chair, BC Ministry UBC Faculty of Medicine UBCEmergency Faculty of Medicine - BC Ministry Centre for Health UBC Faculty of Medicine Centre for Health Drug Benefits CommitCommittee (Health(Health of Health Drug Benefits CommitCommittee of Expensive Health Expensive Medicine,Vancouver Department Population Evaluation and General Evaluation andSchool of School of Population tee Technology Assessment Drugs for Rarefor Diseases tee Technology Assessment Drugs Rare Diseases of Emergency Medicine Outcome SciencesSciencesand Public Hospital andHealth Public Health Outcome Committee) Committee Committee) Advisory Advisory Committee UBC Faculty of Medicine, BC Ministry of Health BC Ministry of -Health General of Centre for Health UBC Faculty of Landof and Department Centre for HealthVancouver UBC Faculty Land and Drug Review and and Mary De VeraDe VeraVice-Chair, Canadian Drug Review Mary Vice-Chair, Canadian and and Hospital Food Systems Emergency Medicine Resources Food Systems Evaluation Evaluation Committee Pharmacy Residency Resources Committee Pharmacy Residency Outcome Sciences Outcome Sciences BC Ministry of Health Board Standards BC Ministry of Health Board Standards Women’s Health Health Vancouver General Women’s Do BugsDo Need Data Data Committee BugsDrugs Need DrugsPharmanet Pharmanet Committee Mohsen Sadatsafavi Research InstituteInstitute Hospital Research Program, BC Centre Stewardship Comittee Program, BC for Centre for Stewardship Comittee Mark Harrison Mark Harrison DiseaseDisease ControlControl Association of Faculties Association of Faculties Centre for Clinical FawziahFawziah Lalji Lalji Peter Zed Education Peter Zed of Pharmacy of Pharmacy Education Mohsen and Sadatsafavi Larry Lynd Committee Centre for Health Larry Lynd Committee Centre for HealthEpidemiology Evaluation Vice Chair, Benefits Association of Faculties ViceDrug Chair, Drug Benefits Association of Faculties UBC Faculty of Medicine Evaluation and and UBC Faculty of Medicine Evaluation Centre for Clinical BC Ministry of Health Council,Council, BC Ministry of of Pharmacy EducationBC Ministry of Health BC Ministry of of Pharmacy EducationOutcome Sciences DivisionDivision of Infectious Outcome Sciences of Infectious Expensive Drugs for Health Health al Outcomes Steering UBC Faculty of Medicine and Expensive Drugs for al Outcomes Steering Epidemiology DiseasesDiseases Rare Diseases Advisory Committee Rare Diseases Advisory Committee Division of Respiratory Evaluation ArthritisArthritis Research Research Committee Ministry of Committee Chair, BC Chair, BC Ministry of Medicine BC Centre Disease BC for Centre for Disease CanadaCanada Health Drug Review BC Health Health Drug Review BC Authorities Health Authorities UBC Faculty of Medicine ControlControl Respiratory/Allergy & TherapeuRespiratory/Allergy and Resources and ResourcesPharmacy Pharmacy & TherapeuNeuroethics CanadaCanada Division of Respiratory Neuroethics Therapies - Health- Health Committee tics Committee Therapies Committee tics Committee Medicine Mary De VeraDe Vera Mary CanadaCanada Special Special Advisory Advisory Peter Loewen Peter Loewen Committee Health Health Committee Non-Insured Non-Insured ArthritisArthritis Research Research Benefits,Benefits, Health Canada Health Canada Vancouver GeneralGeneral CanadaCanada Vancouver - Drugs -and TherapeuDrugs and TherapeuHospitalHospital tics Advisory Committee tics Advisory Committee (DTAC) (DTAC)

CROSS CROSS MAJOR MAJOR COMMITTEE COMMITTEE APPOINTMENTS APPOINTMENTS APPOINTMENTS APPOINTMENTS

INTERNATIONAL PRIVATEPRIVATE SECTORSECTOR INTERNATIONAL COLLABORATIONS COLLABORATIONS COLLABORATIONS COLLABORATIONS

Annalijn ConklinConklin MohsenMohsen Sadatsafavi Annalijn Sadatsafavi Visiting Visiting Researcher, Researcher, Core Member, Core Member, Respiratory EffectiveUniversity of Cambridge University of Cambridge Respiratory EffectiveMRC Epidemiology Unit, ness MRC Epidemiology Unit,Group, ness England Group, England EnglandEngland International Severe Mark Harrison Larry Lynd Larry Lynd Asthma Registry Senior Research Fellow, Training,Training, Support,Support, & Harrisonof Manches&Mark University Mentorship Project, Project, Mentorship ter Honorary AppointMaternal, Newborn and Senior Fellow, ment, United Kingdom Maternal, Newborn and Research Child Health, University of ManchesChild Rwanda Health, Rwanda ter Honorary AppointFamily Farms the forment, Familyfor Farms the United Kingdom Future, Cambodia Future, Cambodia

9

REPORT 2018 ANNUAL REPORT 9 2018 ANNUAL


Teaching Teaching Undergraduate Courses Undergraduate Courses PHRM 100 -100 Foundations of Pharmacy: PHRM - Foundations of Pharmacy: Pharmacist, Patient, and and Healthcare Pharmacist, Patient, Healthcare Systems Systems

PHAR 311 -311 Medication Management IV IV PHAR - Medication Management PHAR 312 -312 Medication Management V V PHAR - Medication Management

PHRM 111 -111 Medication Management I PHRM - Medication Management I PHRM 131 -131 Study Design & InterpretaPHRM - Study Design & Interpretation tion I I PHRM 211 -211 Medication Management II II PHRM - Medication Management PHRM 212 -212 Medication Management PHRM - Medication Management III III

PHAR 440 - Pain and Research Therapy PHAR 440 - Pain and Research Therapy PHAR 456 - Applied Pharmacoeconomics PHAR 456 - Applied Pharmacoeconomics PHRM 481 -Healthcare Quality Improvement PHRM 481 -Healthcare Quality Improvement

PHRM 231PHRM - Study Interpre231Design - Studyand Design and tation II Interpretation II

Graduate Courses Graduate Courses PHAR 560/ SPPH 549 549 - Advanced Economic Evaluation in Health CareCare PHAR 560/ SPPH - Advanced Economic Evaluation in Health PHAR 533 533 - Clinical Clerkships I I  PHAR - Clinical Clerkships PHAR 591 -591 Scholarly Integrity andand Research Ethics PHAR - Scholarly Integrity Research Ethics

2018 2018 ANNUAL REPORT ANNUAL REPORT 10

10


Annual Retreat One of the highlights of 2018 was holding the inaugural CORE Annual Retreat. A huge success, the event was hosted at the enchanted False Creek - Creekside Community Centre, and was made possible thanks to generous sponsors from Merck and Boehringer Ingelheim. In the morning session, the breadth of CORE research was showcased in a number of presentations including those that paired CORE faculty with respective trainees. Topics discussed were: Creating a niche in outcomes evaluation for precision medicine - the RESP precision medicine initiative

Dr. Mohsen Sadatsafavi & Kate Johnson, PhD Student

Unpacking the intersections for better chronic disease prevention and management Dr. Annalijn Conklin

Patient-oriented pharmaceutical and health outcomes research Dr. Mary De Vera & Nicole Tsao, PhD Candidate

Appropriate and effective health care: from individuals to populations Dr. Mark Harrison & Ross Duncan, MSc Student

Population and public health research and the 13-valent pneumococcal conjugate vaccine Dr. Fawziah Lalji & Nirma Vadlamudi, PhD Student

Health economics of genome-wide sequencing Dr. Larry Lynd & Dr. Nick Dragojlovic, Research Associate

The afternoon featured an insightful visioning session lead by Dr. Larry Lynd. This included a Strenghts, Weaknesses, Opportunities and Threats (SWOT) analysis to discuss how CORE faculty, staff, and trainees envision CORE, challenges faced, and identifying areas for continued development for CORE. The day concluded with a team building activity out on the False Creek waters where the CORE team went Dragon boating.

11

2018 ANNUAL REPORT


DRAGON BOATING 2018 ANNUAL REPORT

12


CONTACT CORE.UBC.CA EMPHASIS.CORE.UBC.CA MILLIONDOLLARMEDS.COM PHARMSCI.UBC.CA RARE-DISEASES.CA RESP.CORE.UBC.CA

Collaboration for Outcomes Research and Evaluation (CORE) 2405 Wesbrook Mall Vancouver, BC Canada V6T 1Z3 1.604.822.9460 EMAIL TWITTER TWITTER FACEBOOK

info@core.ubc.ca @CORE_UBC @RareDxResearch COREatUBC

Editor & Designer Alexander Lin Photographer Justin Ohata For questions or comments info@core.ubc.ca 2018 CORE

Profile for UBC Pharmaceutical Sciences CORE

2018 CORE Annual Report  

As they continue to grow and strive for positive change, the Collaboration for Outcomes Research and Evaluation (CORE) group invites you to...

2018 CORE Annual Report  

As they continue to grow and strive for positive change, the Collaboration for Outcomes Research and Evaluation (CORE) group invites you to...

Advertisement